(Q50993680)

English

A mir-153 binding site variation in SNCA in a patient with Parkinson's disease.

scientific article published on 14 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

A mir-153 binding site variation in SNCA in a patient with Parkinson's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Parkinson's disease

1 reference

based on heuristic

inferred from title

1

object named as

Han-Joon Kim

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

3

object named as

Beom S Jeon

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

author name string

Gibeom Park

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Woong Yang Park

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Young Eun Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

language of work or name

0 references

publication date

14 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

28

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

12

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

1755-1756

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

Repression of alpha-synuclein expression and toxicity by microRNA-7.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

Variants in the 3'UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25505

21 January 2018

Identifiers

10.1002/MDS.25505

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23674501

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50993680&oldid=1251871553"